MG
RGEN icon

Marex Group’s Repligen RGEN Stock Holding History

Marex Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$656K Buy
+5,572
New +$778K ﹤0.01% 552

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Marex Group's RGEN Position: Q1 2026 in Review

Marex Group opened a new position in Repligen (RGEN) in Q1 2026: 5,572 shares worth $656K. The stake represents ﹤0.01% of the portfolio and ranks #552 among its holdings.

441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Marex Group held 5,572 shares of Repligen worth $656K as of Q1 2026.
  • Repligen was a new Marex Group position in Q1 2026.
  • Repligen made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #552 holding.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.